業績 (代表的なもの) |
■論文
- Horiuchi S, Koda N, Ikeda Y, Tanaka Y, Masuo Y, Kato Y, Yamazaki D. Examination of common culture medium for human hepatocytes and engineered heart tissue: Towards an evaluation of cardiotoxicity associated with hepatic drug metabolism in vitro. PLoS One. 19, e0315997, 2024. https://pubmed.ncbi.nlm.nih.gov/39715174/
- Mizoi K, Okada R, Mashimo A, Masuda N, Itoh M, Ishida S, Yamazaki D, Ogihara T. Novel Screening System for Biliary Excretion of Drugs Using Human Cholangiocyte Organoid Monolayers with Directional Drug Transport. Biol Pharm Bull. 47, 427-433, 2024.
https://pubmed.ncbi.nlm.nih.gov/38369341/
- Uchiyama Y, Yamazaki D, Kobayashi N, Kanda Y, Sugita-Konishi Y. Electrophysiological Effect of Citreoviridin on Human InducedPluripotent Stem Cell-derived Cardiomyocytes. Shokuhin Eiseigaku Zasshi. 63, 210-217, 2023.
https://pubmed.ncbi.nlm.nih.gov/36575035/
- Zhou X, Park KH, Yamazaki D, K Lin PH, Nishi M, Ma Z, Qiu L, Murayama T, Zou X, Takeshima H, Zhou J, Ma J. TRIC-A Channel Maintains Store Calcium Handling by Interacting With Type 2 Ryanodine Receptor in Cardiac Muscle. Circulation Research. 2020 Feb 14;126(4):417-435.
https://pubmed.ncbi.nlm.nih.gov/31805819/
- Nishimura A, Shimoda K, Tanaka T, Toyama T, Nishiyama K, Shinkai Y, Numaga-Tomita T, Yamazaki D, Kanda Y, Akaike T, Kumagai Y, Nishida M. Depolysulfidation of Drp1 induced by low-dose methylmercury exposure increases cardiac vulnerability to hemodynamic overload. Science Signaling. 2019 Jun 25;12(587).
https://pubmed.ncbi.nlm.nih.gov/31239323/
- Yamada S, Yamazaki D, Kanda Y. 5-Fluorouracil inhibits neural differentiation via Mfn1/2 reduction in human induced pluripotent stem cells. Journal of Toxicological Science. 43, 727-734, 2018.
https://pubmed.ncbi.nlm.nih.gov/30518710/
- Yamada S, Kubo Y, Yamazaki D, Sekino Y, Nomura Y, Yoshida S, Kanda Y. Tributyltin Inhibits Neural Induction of Human Induced Pluripotent Stem Cells. Scientific Reports. 8, 12155, 2018.
https://pubmed.ncbi.nlm.nih.gov/30108368/
- Yamada S, Yamazaki D, Kanda Y. Silver nanoparticles inhibit neural induction in human induced pluripotent stem cells. Nanotoxicology, 12, 836-846, 2018.
https://pubmed.ncbi.nlm.nih.gov/29902946/
- Yamazaki D, Kitaguchi T, Ishimura M, Taniguchi T, Yamanishi A, Saji D, Takahashi E, Oguchi M, Moriyama Y, Maeda S, Miyamoto K, Morimura K, Ohnaka H, Tashibu H, Sekino Y, Miyamoto N, Kanda Y. Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes. Journal of Pharmacological Sciences, 136, 249-256, 2018.
https://pubmed.ncbi.nlm.nih.gov/27554434/
■総説
- Yamazaki D, Ishida S. Global expansion of microphysiological systems (MPS) and Japan's initiatives: Innovation in pharmaceutical development and path to regulatory acceptance. Drug Metab Pharmacokinet. 60, 101047, 2025.
https://pubmed.ncbi.nlm.nih.gov/39847978/
- Aoi T, Asaka I, Akutsu H, Ito Y, Kataoka K, Kanda Y, Kojima H, Sekino Y, Suemori H, Nakagawa M, Nakamura K, Nakamura Y, Fujii M, Furue M, Yamazaki D. Japanese Working Group for Consideration of Good Cell Culture Practice. In Vitro Cell Dev Biol Anim. 60, 563-568, 2024.
https://pubmed.ncbi.nlm.nih.gov/38472720/
- Parish ST, Aschner M, Casey W, Corvaro M, Embry MR, Fitzpatrick S, Kidd D, Kleinstreuer NC, Lima BS, Settivari RS, Wolf DC, Yamazaki D, Boobis A. An evaluation framework for new approach methodologies (NAMs) for human health safety assessment. Regulatory Toxicology and Pharmacology. 2020 Apr;112:104592.
https://pubmed.ncbi.nlm.nih.gov/32017962/
- Kanda Y, Yamazaki D, Osada T, Yoshinaga T, Sawada K. Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update. Journal of Pharmacological Sciences. 138, 233-239, 2018.
https://pubmed.ncbi.nlm.nih.gov/30415824/
- Pamies D, Bal-Price A, Simeonov A, Tagle D, Allen D, Gerhold D, Yin D, Pistollato F, Inutsuka T, Sullivan K, Stacey G, Salem H, Leist M, Daneshian M, Vemuri MC, McFarland R, Coecke S, Fitzpatrick SC, Lakshmipathy U, Mack A, Wang WB, Yamazaki D, Sekino Y, Kanda Y, Smirnova L, Hartung T. Good Cell Culture Practice for stem cells and stem-cell-derived models. ALTEX, 34, 95-132, 2017.
https://pubmed.ncbi.nlm.nih.gov/29555184/
|